Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention | Zendy

Rotem Petranker | Zendy; Thomas Anderson | Zendy; Larissa J. Maier | Zendy; Monica J. Barratt | Zendy; Jason Ferris | Zendy; Adam Winstock | Zendy

Open Access

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention

Author(s) -

Rotem Petranker,

Thomas Anderson,

Larissa J. Maier,

Monica J. Barratt,

Jason Ferris,

Adam Winstock

Publication year - 2020

Publication title -

journal of psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.333

H-Index - 114

eISSN - 1461-7285

pISSN - 0269-8811

DOI - 10.1177/0269881120953994

Subject(s) - psilocybin , microdose , psychology , hallucinogen , lysergic acid diethylamide , nocebo effect , pharmacology , clinical psychology , placebo , medicine , psychiatry , alternative medicine , receptor , pathology , serotonin

Microdosing psychedelics is the practice of taking small, sub-hallucinogenic doses of lysergic acid diethylamide or psilocybin-containing mushrooms. Despite its surging popularity, little is known about the specific intentions to start microdosing and the effects of this practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research